Holoclara Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $16M

  • Investors
  • 11

Holoclara General Information

Description

Provider of immunotherapy services intended to bring relief to people suffering from autoimmune disorders. The company offers a range of services, including the delivery of nematode-derived molecules with potent therapeutic properties and the identification of molecules derived from worm species to develop into safe, orally available therapeutics, enabling patients to lead a healthy and safe life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Post Office Box 515381
  • PMB 24549
  • Los Angeles, CA 90051
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • Post Office Box 515381
  • PMB 24549
  • Los Angeles, CA 90051
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Holoclara Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 27-Jun-2024 $16M Completed Generating Revenue
3. Later Stage VC 01-Jan-2022 Completed Generating Revenue
2. Seed Round 01-Sep-2019 $5.7M $5.7M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Holoclara’s complete valuation and funding history, request access »

Holoclara Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Seed 3
Seed 2 691,637 $0.000010 $0.83 $0.83 1x $0.83 2.26%
Seed 1 2,211,194 $0.000010 $0.78 $0.78 1x $0.78 7.21%
To view Holoclara’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Holoclara Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of immunotherapy services intended to bring relief to people suffering from autoimmune disorders. The company o
Drug Delivery
Los Angeles, CA
7 As of 2026

Seal Beach, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Holoclara Competitors (23)

One of Holoclara’s 23 competitors is Dendreon, a Formerly VC-backed company based in Seal Beach, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dendreon Formerly VC-backed Seal Beach, CA
Volastra Venture Capital-Backed New York, NY
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Allorion Therapeutics Venture Capital-Backed Natick, MA
Navrogen Venture Capital-Backed Cheyney, PA
You’re viewing 5 of 23 competitors. Get the full list »

Holoclara Patents

Holoclara Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220409650-A1 Compositions and methods for ascaroside modification of mammalian microbiota Inactive 03-Jun-2019
WO-2020247480-A1 Compositions and methods for ascaroside modification of mammalian microbiota Inactive 03-Jun-2019
CA-3140784-A1 Ascaroside derivatives and methods of use Pending 17-May-2019
EP-3969460-A1 Ascaroside derivatives and methods of use Pending 17-May-2019
EP-3969460-A4 Ascaroside derivatives and methods of use Pending 17-May-2019 A61K31/7028
To view Holoclara’s complete patent history, request access »

Holoclara Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Holoclara Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endurance28 Venture Capital Minority
Freeflow Ventures Venture Capital Minority
Horizons Ventures Venture Capital Minority
K5 Global Venture Capital Minority
NIH Seed Not-For-Profit Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Holoclara FAQs

  • When was Holoclara founded?

    Holoclara was founded in 2017.

  • Where is Holoclara headquartered?

    Holoclara is headquartered in Los Angeles, CA.

  • What is the size of Holoclara?

    Holoclara has 7 total employees.

  • What industry is Holoclara in?

    Holoclara’s primary industry is Drug Delivery.

  • Is Holoclara a private or public company?

    Holoclara is a Private company.

  • What is the current valuation of Holoclara?

    The current valuation of Holoclara is .

  • What is Holoclara’s current revenue?

    The current revenue for Holoclara is .

  • How much funding has Holoclara raised over time?

    Holoclara has raised $21.7M.

  • Who are Holoclara’s investors?

    Endurance28, Freeflow Ventures, Horizons Ventures, K5 Global, and NIH Seed are 5 of 11 investors who have invested in Holoclara.

  • Who are Holoclara’s competitors?

    Dendreon, Volastra, Ability Pharma, Allorion Therapeutics, and Navrogen are some of the 23 competitors of Holoclara.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process